The Centers for Medicare & Medicaid Services is accepting applications from eligible entities — including hospitals that employ clinicians, critical access hospitals and rural health clinics — to participate in the Primary Care Initiative’s professional and global direct contracting options in calendar year 2020. Both options offer capitated payment and performance-based shared savings and losses. Participants in the professional option will retain half of any savings and pay back half of any losses to Medicare under the model, while participants in the global option will retain all savings and pay back any losses. The 2020 implementation period will provide an opportunity for direct contracting entities, especially those who have not traditionally provided services to a Medicare fee-for-service population, to conduct outreach for voluntary alignment of beneficiaries to the model. CMS plans to open an application period next spring for entities interested in starting in 2021, the first of five performance years for the model. Prospective applicants who have not already submitted a non-binding letter of intent to apply must do so by Dec. 10. For more information, see the CMS factsheet.  

Headline
The 4th U.S. Circuit Court of AppealsMay 28 agreed to rehear challenges to 340B contract pharmacy laws from West Virginia and Maryland. In April, a three-judge…
Headline
The Centers for Medicare & Medicaid Services May 28 issued a final rule making changes to the Increasing Organ Transplant Access Model beginning July 1.…
Headline
Rep. Randy Feenstra, R-Iowa, yesterday introduced a House version of the Rural Community Hospital Demonstration Program Reauthorization Act, a bill that would…
Headline
Rep. Randy Feenstra, R-Iowa, introduced the Rural Maternity Options for Medical Support Act on May 19. The bill would guarantee that beds used solely for labor…
Headline
The AHA May 20 provided comments to the House Energy and Commerce Subcommittee on Health for a hearing on the physician fee schedule, the Medicare Access…
Headline
The Wall Street Journal today published a letter to the editor from AHA General Counsel Chad Golder responding to a May 7 editorial criticizing the 340B Drug…